Feb 23 | Nov 22 | Nov 21 | |
---|---|---|---|
Income Statement | - | ||
Total Revenue | - | - | C$ 0.00 |
Gross Profit | - | - | - |
EBIT | C$ -66.85K | C$ -33.45K | C$ -6.91K |
EBITDA | C$ -66.85K | C$ -33.45K | C$ -6.91K |
Net Income Common Stockholders | C$ -66.85K | C$ -33.45K | C$ -6.84K |
Balance Sheet | - | ||
Cash Cash Equivalents And Short Term Investments | C$ 262.22K | C$ 597.54K | - |
Total Assets | C$ 602.47K | C$ 646.35K | - |
Total Debt | C$ 0.00 | C$ 0.00 | C$ 0.00 |
Net Debt | C$ -262.22K | C$ -597.54K | C$ 0.00 |
Total Liabilities | C$ 13.89K | C$ 15.91K | - |
Stockholders Equity | C$ 588.58K | C$ 630.45K | - |
Cash Flow | - | ||
Free Cash Flow | C$ -333.31K | C$ -40.17K | C$ -6.63K |
Operating Cash Flow | C$ -166.15K | C$ -38.53K | C$ -6.63K |
Investing Cash Flow | C$ -167.16K | C$ -1.64K | C$ 0.00 |
Financing Cash Flow | C$ -2.02K | C$ 518.43K | C$ 0.00 |